Company Also Spotlights How its Glycan Analysis Kit Has Saved
Biopharmaceutical Industry Nearly Four Years of Lab Work
Waters Corporation (NYSE:WAT) today unveiled its new line of
differential scanning calorimeters reaffirming TA Instruments' position
as the technology and global leader in thermal analysis at the 2016 Pittsburgh
Conference on Analytical Chemistry and Applied Spectroscopy.
Additionally, the company highlighted new CORTECS®
column chemistries and reported that its GlycoWorks™ RapiFluor-MS™
N-Glycan Kit has already saved biopharmaceutical laboratories
industry-wide approximately four years of work based on sales in just
its first year of availability.
"Innovation is the engine that drives Waters," said Christopher J.
O'Connell, President and CEO of Waters Corporation. "From the days of
Jim Waters, our commitment to innovation has been deeply engrained in
the organization's make-up. For decades, the organization's central
focus has been to innovate and push the boundaries of analytical science
to develop and support the technologies that enable our customers around
the globe to be successful. Seeing the comprehensive product portfolio
from Waters and TA Instruments here at Pittcon underscores the company's
innovation leadership."
Three new Discovery DSC systems
The new line of Differential
Scanning Calorimeters, the Discovery DSC 2500, DSC 250, and DSC 25
feature enhanced sensing technologies resulting in unprecedented
performance in baseline flatness, sensitivity, resolution, and
reproducibility.
At the core of every new Discovery DSC is the exclusive TA Fusion Cell™,
which incorporates design concepts that “fuse” together features of the
Q-Series and first generation Discovery DSC, patented Tzero®
technology, and new proprietary manufacturing processes. Additionally,
an app-style user interface is standard with each new model and combined
with powerful new TRIOS software, automated calibration and verification
routines work seamlessly to dramatically improve laboratory work-flows
and productivity.
The Discovery DSC measures the change in energy in a sample as the
temperature is raised or lowered. It is used for a wide range of
applications, including material science, pharmaceuticals, chemistry and
studies of biomaterials. It excels in both research environments and
production control processes.
"DSC is the anchor of a thermal analysis laboratory," said Terry Kelly,
President of TA Instruments. "In terms of performance and ease-of-use
the new Discovery Series DSC is so advanced, that upgrading to one of
our powerful new systems will bring scientists lasting benefits."
The DSC 2500 comes standard with all options, which includes the all-new
linear autosampler that allows for enhanced flexibility in assigning
sample and reference pans to any combination of the available 54
positions. We believe that it is the only DSC on the market capable of
making and storing heat capacity measurements in a single run.
The DSC 250 is a flexible and configurable research-grade DSC that
includes Tzero technology, and is well-equipped to satisfy the most
demanding researcher. The DSC 25 is a cost-effective, easy to use,
general purpose DSC with performance superior to competitive research
grade systems. It is ideal for research, teaching, and quality control
laboratories that require a rugged, reliable, basic DSC.
GlycoWorks Saves Industry Nearly Four Years of Work
Emphasizing the impact of its innovations, Waters revealed that its
GlycoWorks RapiFluor-MS N-Glycan Kit has already saved
biopharmaceutical laboratories industry wide approximately four years of
work in just its first year of availability. These calculations are
based on purchases by all 15 top revenue generating pharmaceutical
companies and 90% of the top biopharmaceutical companies with
glycoproteins in their pipeline.
Most biotherapeutic proteins available on the market today are
glycoproteins. The heterogeneous glycan populations on these proteins
are critical quality attributes that affect potency, stability, and
therapeutic safety profiles. As a result, biopharmaceutical companies
must provide detailed structural information pertaining to the glycans
attached to their biotherapeutics when submitting new applications to
regulatory authorities and on an ongoing basis throughout the
manufacturing process. Waters estimates about 4.4 million released
glycan analyses are performed per year, and that number is growing at
double digit rates.
A ground-breaking technology for characterizing glycoproteins, the
GlycoWorks RapiFluor-MS N-Glycan Kit combined with Waters' ACQUITY
UPLC® System, the ACQUITY
UPLC® FLR Detector and the ACQUITY®
QDa® Detector, and enables scientists to analyze released
N-glycans and achieve new levels of speed, sensitivity, simplicity while
obtaining previously unattainable structural information.
Expansion of CORTECS Solid-Core LC Columns
Waters today added to its CORTECS®
Columns product family with the introduction of two new LC column
chemistries. Built on Waters proven solid-core particle technology, the
Waters® CORTECS® C8 and CORTECS®
Phenyl analytical columns are designed for scientists who need to expand
their chromatographic separation space while maximizing the speed,
resolution and sensitivity of their small molecule HPLC, UHPLC or UPLC®
separations. Capable of operating at very high column efficiencies and
low backpressures, the new columns give scientists additional
selectivity choices and allow them to develop methods quickly, and
generate more information with every analytical run. The CORTECS C8
and CORTECS Phenyl chemistries are available in two particle sizes, 1.6
and 2.7 micron, and are offered in a total of 50 unique column
configurations.
CORTECS C8 Columns exhibit a lower hydrophobicity when
compared to typical bonded C18 phases and are useful for
separating strongly hydrophobic compounds. They are also ideal for
chemists looking to transfer or scale compendial C8 HPLC
methods to a more robust column technology.
CORTECS Phenyl Columns are an excellent alternative to typically bonded C18
phases, particularly for aromatic compounds, based on the unique
selectivity provided by the Phenyl bonded phase.
For More on Waters at Pittcon
Also being shown for the first time at Pittcon are the Waters®
ACQUITY Arc™ System, VionTM
IMS QTofTM Mass Spectrometer, and HDI®
Software. For a comprehensive view of Waters' activities at Pittcon
2016, including a full list of products, in-booth activities and
technical presentations, please visit www.waters.com/pittcon.
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT) develops and manufactures advanced
analytical and material science technologies for laboratory dependent
organizations. For more than 50 years, the company has pioneered a
connected portfolio of separations science, laboratory information
management, mass spectrometry and thermal analysis systems.
Waters, GlycoWorks, RapiFluor-MS, ACQUITY, ACQUITY Arc, ACQUITY
UPLC, UPLC, Vion, CORTECS, Fusion Cell, Discovery DSC, Tzero, QDa, HDI,
and The Science of What’s Possible are trademarks of Waters Corporation.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160307005346/en/
Copyright Business Wire 2016